DD202561A5 - Verfahren zur Herstellung von Salzen von Naphthyridin- und Chinolin-verbindungen - Google Patents
Verfahren zur Herstellung von Salzen von Naphthyridin- und Chinolin-verbindungen Download PDFInfo
- Publication number
- DD202561A5 DD202561A5 DD24062982A DD24062982A DD202561A5 DD 202561 A5 DD202561 A5 DD 202561A5 DD 24062982 A DD24062982 A DD 24062982A DD 24062982 A DD24062982 A DD 24062982A DD 202561 A5 DD202561 A5 DD 202561A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- acid
- compound
- solution
- salts
- gluconate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27260181A | 1981-06-11 | 1981-06-11 | |
US33418281A | 1981-12-24 | 1981-12-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
DD202561A5 true DD202561A5 (de) | 1983-09-21 |
Family
ID=26955624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD24062982A DD202561A5 (de) | 1981-06-11 | 1982-06-10 | Verfahren zur Herstellung von Salzen von Naphthyridin- und Chinolin-verbindungen |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0067666B1 (ko) |
KR (1) | KR880002087B1 (ko) |
AU (1) | AU551596B2 (ko) |
CA (1) | CA1191842A (ko) |
DD (1) | DD202561A5 (ko) |
DE (1) | DE3267135D1 (ko) |
DK (1) | DK155998C (ko) |
ES (1) | ES512969A0 (ko) |
FI (1) | FI78292C (ko) |
GR (1) | GR77194B (ko) |
HU (1) | HU188181B (ko) |
IE (1) | IE53259B1 (ko) |
IL (1) | IL66027A (ko) |
NO (1) | NO157739C (ko) |
NZ (1) | NZ200908A (ko) |
PH (1) | PH19091A (ko) |
SU (1) | SU1192624A3 (ko) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3318145A1 (de) * | 1983-05-18 | 1984-11-22 | Bayer Ag, 5090 Leverkusen | 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel |
DE3333719A1 (de) * | 1983-09-17 | 1985-04-04 | Bayer Ag | Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren |
IT1196051B (it) * | 1984-03-16 | 1988-11-10 | Schiena Ricerche | Composti ad attivita' antibatterica |
DE3517709A1 (de) * | 1985-01-05 | 1986-07-10 | Bayer Ag | Basische zubereitungen von chinoloncarbonsaeuren |
US4657913A (en) * | 1985-04-18 | 1987-04-14 | Warner-Lambert Company | Trifluoro- quinoline -3- carboxylic acids and their use as anti-bacterial agents |
HUT40429A (en) * | 1985-04-29 | 1986-12-28 | Chinoin Gyogyszer Es Vegyeszet | Process for production of salts of derivatives of kynolin carbonic acid |
DE3525335A1 (de) * | 1985-07-16 | 1987-01-22 | Bayer Ag | Embonate von chinoloncarbonsaeuren und ihren derivaten |
DE3537761A1 (de) * | 1985-10-24 | 1987-04-30 | Bayer Ag | Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure |
IT1196429B (it) * | 1986-07-01 | 1988-11-16 | Mediolanum Farmaceutici Srl | Processo per la preparazione di pirido benzotiazine ad attivita' antibatterica e loro sali con acidi solfonici |
IL80459A (en) * | 1986-10-30 | 1991-04-15 | Abic Ltd | Water-soluble adduct of norfloxacin and nicotinic acid |
US5188833A (en) * | 1987-12-28 | 1993-02-23 | Kyorin Seiyaku Kabushiki Kaisha | Freeze-dried pharmaceutical preparations for parenteral use |
JPH01175935A (ja) * | 1987-12-28 | 1989-07-12 | Kyorin Pharmaceut Co Ltd | 凍結乾燥注射剤 |
US4948894A (en) * | 1989-02-21 | 1990-08-14 | American Cyanamid Company | 8-fluoro and 7, 8, 10-trifluoro-9-(substituted)-6-oxo-6H-benzo-(C)quinolizine-5-carboxylic acids |
KR0159540B1 (ko) * | 1992-01-21 | 1998-12-01 | 김정순 | 퀴놀론-카복실산의 염 및 그 함유조성물 |
ES2127036B1 (es) * | 1994-03-21 | 1999-11-16 | Ind Quimica Agropecuaria S A | Aducto de norfloxacina soluble en agua. |
ES2088742B1 (es) * | 1994-06-29 | 1997-03-16 | Salvat Lab Sa | Composicion antibiotica de aplicacion otica. |
DE19500784A1 (de) * | 1995-01-13 | 1996-07-18 | Bayer Ag | Enrofloxacin-Injektions- oder Infusionslösungen |
MA24500A1 (fr) | 1997-03-21 | 1998-10-01 | Lg Life Sciences Ltd | Derive du sel d'acide carboxylique de naphthyridine . |
DK2134712T3 (da) | 2007-04-13 | 2013-11-18 | Dong Wha Pharm Co Ltd | Aspartat af 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza-spiro(3, 4)oct-6-yl)-4-oxo-1,4-dihydro-(1,8) naphthyridin-3-karboxylsyre, fremgangsmåde til fremstilling af samme og antimikrobielt farmaceutisk sammensætning omfattende samme |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR223983A1 (es) * | 1978-08-25 | 1981-10-15 | Dainippon Pharmaceutical Co | Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico |
ZA811304B (en) * | 1980-03-11 | 1982-06-30 | Warner Lambert Co | Pharmaceutical salts of 4'-(9-acridinylamino)methanesulfon-m-anisidide |
-
1982
- 1982-06-09 ES ES512969A patent/ES512969A0/es active Granted
- 1982-06-09 HU HU821866A patent/HU188181B/hu unknown
- 1982-06-10 CA CA000404864A patent/CA1191842A/en not_active Expired
- 1982-06-10 GR GR68389A patent/GR77194B/el unknown
- 1982-06-10 DD DD24062982A patent/DD202561A5/de unknown
- 1982-06-10 DK DK261582A patent/DK155998C/da not_active IP Right Cessation
- 1982-06-10 NO NO821931A patent/NO157739C/no unknown
- 1982-06-10 NZ NZ200908A patent/NZ200908A/en unknown
- 1982-06-10 KR KR8202588A patent/KR880002087B1/ko active
- 1982-06-10 SU SU823450276A patent/SU1192624A3/ru active
- 1982-06-10 IL IL66027A patent/IL66027A/xx unknown
- 1982-06-10 DE DE8282302997T patent/DE3267135D1/de not_active Expired
- 1982-06-10 FI FI822066A patent/FI78292C/fi not_active IP Right Cessation
- 1982-06-10 IE IE1390/82A patent/IE53259B1/en not_active IP Right Cessation
- 1982-06-10 PH PH27408A patent/PH19091A/en unknown
- 1982-06-10 AU AU84757/82A patent/AU551596B2/en not_active Ceased
- 1982-06-10 EP EP82302997A patent/EP0067666B1/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
PH19091A (en) | 1985-12-19 |
KR880002087B1 (ko) | 1988-10-15 |
NO157739C (no) | 1988-05-11 |
IL66027A (en) | 1986-02-28 |
FI822066A0 (fi) | 1982-06-10 |
ES8304117A1 (es) | 1983-02-16 |
NO157739B (no) | 1988-02-01 |
NO821931L (no) | 1982-12-13 |
KR840000544A (ko) | 1984-02-25 |
CA1191842A (en) | 1985-08-13 |
EP0067666B1 (en) | 1985-10-30 |
EP0067666A1 (en) | 1982-12-22 |
DK261582A (da) | 1982-12-12 |
IE821390L (en) | 1982-12-11 |
SU1192624A3 (ru) | 1985-11-15 |
IL66027A0 (en) | 1982-09-30 |
ES512969A0 (es) | 1983-02-16 |
AU551596B2 (en) | 1986-05-08 |
IE53259B1 (en) | 1988-09-28 |
HU188181B (en) | 1986-03-28 |
DE3267135D1 (en) | 1985-12-05 |
GR77194B (ko) | 1984-09-11 |
DK155998C (da) | 1989-11-06 |
FI78292B (fi) | 1989-03-31 |
AU8475782A (en) | 1982-12-16 |
NZ200908A (en) | 1984-09-28 |
FI78292C (fi) | 1989-07-10 |
DK155998B (da) | 1989-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DD202561A5 (de) | Verfahren zur Herstellung von Salzen von Naphthyridin- und Chinolin-verbindungen | |
DE60026144T2 (de) | Benzamidformulierung mit histon-deacetylase-inhibitoraktivität | |
DE69005992T2 (de) | Psychotropische Wirkstoffe enthaltende stabilisierte Lösungen. | |
DE69014141T2 (de) | Verwendung von Benzimidazol-Derivaten als antibakterielle Mittel. | |
DE2332878C2 (de) | Salze von Cephalosporinen mit Arginin und Lysin, ihre Herstellung und injizierbare pharmazeutische Zubereitungen | |
DE3031710A1 (de) | Salze von (+)-catechin, deren herstellung und verwendung sowie diese salze enthaltende pharmazeutische zubereitungen. | |
DE60025627T2 (de) | Pharmazeutische lösung von levosimendan | |
EP2865391B1 (de) | Verfahren zur Herstellung einer gefriergetrockneten pharmazeutischen Zusammensetzung mit Gehalt an Mitomycin C | |
EP0806955B1 (de) | Enrofloxacin-injektions- oder infusionslösungen | |
DE3686514T2 (de) | N-(2-carboxy)-ethyl-1,8-naphthalenimid und dessen salze zur behandlung von diabetischen retinopathien und neuropathien. | |
DE3000743A1 (de) | Arzneipraeparat auf der basis eines salzes der acetylsalicylsaeure und einer basischen aminosaeure und verfahren zu seiner herstellung | |
DE19709897A1 (de) | Wismutsalze von Antibiotika der Moenomycin-Gruppe, Verfahren zu ihrer Herstellung, ihre Verwendung und solche Salze enthaltende Arzneimittel | |
DE2460929C2 (ko) | ||
CH647677A5 (de) | 4'-(acridinylamino)-methansulfon-anisidid enthaltende pharmazeutische zusammensetzung. | |
DE69115102T2 (de) | Stabilisator für eine 4-ethyl-2-hydroxyimino-5-nitro-3-hexenamide enthaltende Zusammensetzung und Stabilisierungsverfahren. | |
DE60013583T2 (de) | Verfahren zur herstellung von arzneimitteln eines basischen hydrophoben wirkstoffs | |
DE1965343A1 (de) | Arzneimittel,insbesondere zur Herabsetzung der Schleimviskositaet und Anwendung als hustenstillendes Mittel,und Verfahren zu seiner Herstellung | |
DE2655130C3 (de) | Eine praktisch lösungsmittelfreie Kristallform des Cefacetril-Natriumsalzes | |
DE2236876B2 (de) | N-Substituierte Aminocarbonsäuren und diese Verbindungen enthaltende Arzneimittel | |
DE2461570C3 (de) | Arzneimittel für die Behandlung bakterieller Infektionen der Augen und/oder der Ohren und Verfahren zu ihrer Herstellung | |
EP0061654B1 (de) | Vincamin-cyclamat, Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel | |
DE1620177B2 (de) | N-(2-Hydroxyäthyl) -piperazinocarboxymethyl-te tr acy elin, dessen pharmakologisch verwendbaren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel | |
DE3203274A1 (de) | Vitamin k(pfeil abwaerts)3(pfeil abwaerts)-(gamma)-cyclodextrin-einschlusskomplex, verfahren zu dessen herstellung und diesen einschlusskomplex enthaltende praeparate | |
CH648023A5 (de) | 4'-(9-acridinylamino)methansulfon-m-anisidid-gluconat und dieses enthaltende mischungen. | |
DE69002027T2 (de) | (3-Diethylaminopropyl)-1-amino-5-methyldipyrido[4,3-b][3,4-f]indoltrihydrochlorid. |